Reply
- PMID: 37229791
- DOI: 10.1002/art.42621
Reply
Comment on
-
Risk of arrhythmia among new users of hydroxychloroquine: comment on the article by Hoque et al.Arthritis Rheumatol. 2023 Nov;75(11):2065. doi: 10.1002/art.42618. Epub 2023 Aug 30. Arthritis Rheumatol. 2023. PMID: 37229793 No abstract available.
References
-
- Hoque MR, Lu L, Daftarian N, et al. Risk of arrhythmia among new users of hydroxychloroquine in rheumatoid arthritis and systemic lupus erythematosus: a population-based study. Arthritis Rheumatol 2023;75(3):475-84.
-
- Goldman A, Bomze D, Dankner R, et al. Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports. Br J Clin Pharmacol 2021;87(3):1432-42.
-
- Nguyen LS, Dolladille C, Drici MD, Fet al. Cardiovascular toxicities associated with hydroxychloroquine and azithromycin: an analysis of the World Health Organization pharmacovigilance database. Circulation 2020;142(3):303-5.
-
- Bate A, Evans S. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf 2009;18(6):427-36.
-
- Rawlins MD. Spontaneous reporting of adverse drug reactions. I: the data. Br J Clin Pharmacol 1988;26(1):1-5.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources